Author:
Mekaru Harutaka,Ichiyanagi Yuko,Tamanoi Fuyuhiko
Publisher
Springer International Publishing
Reference49 articles.
1. Maruya A, Singh AK, Mishra G, Kumari K, Rai A, Sharma B, Kulkarni GT, Awasthi R (2019) Strategic use of nanotechnology in drug targeting and its consequences on human health: a focused review. Interv Med Appl Sci 11:38–54
2. Perez-Herrero E, Fernandez-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–790
3. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284
4. Mekaru H, Lu J, Tamanoi F (2015) Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliv Rev 95:40–49
5. Ichiyanagi Y, Moritake S, Taira S, Setou M (2007) Functional magnetic nanoparticles for medical application. J Magn Magn Mater 310:2877–2879
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献